Skip to content
10-Q

Quarterly Report

Crinetics Pharmaceuticals, Inc. CRNX

0001193125-25-175498

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 29, 2025 94.18M sh
Shares Diluted Q2 2025 · Jun 30, 2025 93.79M sh
Shares Diluted Q2 2025 · Jun 30, 2025 93.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 79.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 75.69M sh
Capex Q2 2025 · Jun 30, 2025 $4.44M
Capex Q2 2025 · Jun 30, 2024 $2.29M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$174.3M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$100.5M
Short Term Investments Q2 2025 · Jun 30, 2025 $1.14B
Short Term Investments Q2 2025 · Dec 31, 2024 $1.09B
Cash And Equivalents Q2 2025 · Jun 30, 2025 $53.73M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $264.55M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $302.16M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.17B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.25B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.32B
Stockholders Equity Q2 2025 · Jun 30, 2024 $830.76M
Stockholders Equity Q2 2025 · Mar 31, 2024 $874.93M
Stockholders Equity Q2 2025 · Dec 31, 2023 $539.11M
Current Liabilities Q2 2025 · Jun 30, 2025 $68.4M
Current Liabilities Q2 2025 · Dec 31, 2024 $59.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $118.05M
Total Liabilities Q2 2025 · Dec 31, 2024 $109.79M
Current Assets Q2 2025 · Jun 30, 2025 $1.22B
Current Assets Q2 2025 · Dec 31, 2024 $1.38B
Total Assets Q2 2025 · Jun 30, 2025 $1.29B
Total Assets Q2 2025 · Dec 31, 2024 $1.43B
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.23
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.27
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.94
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.86
Eps Basic Q2 2025 · Jun 30, 2025 −$1.23
Eps Basic Q2 2025 · Jun 30, 2025 −$2.27
Eps Basic Q2 2025 · Jun 30, 2024 −$0.94
Eps Basic Q2 2025 · Jun 30, 2024 −$1.86
Sga Expense Q2 2025 · Jun 30, 2025 $49.84M
Sga Expense Q2 2025 · Jun 30, 2025 $85.37M
Sga Expense Q2 2025 · Jun 30, 2024 $24.84M
Sga Expense Q2 2025 · Jun 30, 2024 $45.67M
Rd Expense Q2 2025 · Jun 30, 2025 $80.3M
Rd Expense Q2 2025 · Jun 30, 2025 $156.54M
Rd Expense Q2 2025 · Jun 30, 2024 $58.34M
Rd Expense Q2 2025 · Jun 30, 2024 $111.69M
Net Income Q2 2025 · Jun 30, 2025 −$115.64M
Net Income Q2 2025 · Jun 30, 2025 −$212.41M
Net Income Q2 2025 · Jun 30, 2024 −$74.06M
Net Income Q2 2025 · Jun 30, 2024 −$140.99M
Operating Income Q2 2025 · Jun 30, 2025 −$129.11M
Operating Income Q2 2025 · Jun 30, 2025 −$240.52M
Operating Income Q2 2025 · Jun 30, 2024 −$82.78M
Operating Income Q2 2025 · Jun 30, 2024 −$156.31M
Revenue Q2 2025 · Jun 30, 2025 $1.03M
Revenue Q2 2025 · Jun 30, 2025 $1.39M
Revenue Q2 2025 · Jun 30, 2024 $399K
Revenue Q2 2025 · Jun 30, 2024 $1.04M